Editorial Code of Conduct
Effective June 4, 2026
Aminoscope covers medicines and interventions that readers use to make real health decisions. That responsibility demands a clear, enforceable standard of conduct for everyone who contributes to the site. The principles below are binding on all Aminoscope writers, editors, and contributors, and they sit alongside our editorial policy and methodology.
1. No Fabrication — Ever
We do not invent, embellish, or misrepresent data, study results, quotes, or citations. We do not cite a paper we have not located in a primary database, attribute a figure to a study that does not contain it, or reconstruct a reference from memory. Every citation is verified live against the source of record before publication. Fabrication or falsification of a source is the most serious breach of this code and is grounds for retraction of the affected work.
2. Accuracy Commitment
We commit to representing the evidence faithfully: reporting effect sizes and uncertainty rather than adjectives, distinguishing strong evidence from preliminary signal, and noting when a therapy is investigational, off-label, or compounded. Where the data are limited, we say so. When we get something wrong, we fix it openly and date the change through our corrections process.
3. Conflicts of Interest
Contributors must disclose to the desk any financial, personal, or professional interest that could reasonably be seen to influence their coverage — for example, a financial stake in a provider or manufacturer being reviewed. Anyone with a material conflict on a given topic is recused from writing or editing the verdict on it. Aminoscope is not paid to publish a particular opinion, and no contributor may accept personal payment, gifts, or other inducements from a company in exchange for coverage.
4. How Commercial Relationships Are Handled
Aminoscope is reader-supported and earns affiliate revenue through clearly labeled partnerships, managed primarily through the Katalys network, in compliance with the FTC's endorsement guides (16 CFR Part 255). These relationships are disclosed on our Disclosures page and near commercial content. Commercial arrangements may determine placement and visibility — and where they do, the placement is labeled — but the existence of a partnership is never a factor in the substance of a review.
5. Advertiser-Influence Prohibition
No advertiser, affiliate partner, or commercial relationship may influence an editorial verdict, a ranking rationale, a score, or a safety statement. A partner cannot buy a higher ranking, a softer assessment, or the removal of unfavorable findings, and declining to partner cannot be punished with a worse one. The editorial firewall described in our editorial policy is absolute, and our Nature of Reviews page explains how verdicts are reached independently of any commercial arrangement.
6. Respect for Readers
We write for readers making consequential decisions, not for clicks. We avoid hype, fear-mongering, and manufactured urgency; we label commercial content clearly; and we always preserve the boundary that our work is research and education, not individualized medical advice — see our medical disclaimer.
7. Reporting a Concern
If you believe a piece of our work breaches this code — a fabricated citation, an undisclosed conflict, a verdict that looks bought — please tell us at editorial@aminoscope.com. We take such reports seriously and will investigate and respond.